CSIMarket Company Name, Ticker, Customers, else..


Pacific Biosciences Of California Inc   (NASDAQ: PACB)
Other Ticker:  
 

Pacific Biosciences Of California Inc

PACB's Fundamental analysis



Pacific Biosciences Of California Inc 's sales fell by -31.45 % in IV. Quarter 2024 from the same quarter a year ago.

Laboratory Analytical Instruments industry recorded growth of revenues by 3.26 %

Pacific Biosciences Of California Inc realized net income compared to net loss a year ago in IV. Quarter 2024

• More on PACB's Growth


Pacific Biosciences Of California Inc
realized a net loss in trailing twelve months.

Pacific Biosciences Of California Inc realized cash reduction of $ -0.64 per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
10.57
PE TTM    
Company's Price to Sales ratio is at 1.65.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.43.


• More on PACB's Valuation
 
 Total Debt (Millions $) 647
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 192,565
 Net Income/Employee (TTM) $ -389,260
 Receivable Turnover (TTM) 5.12
 Tangible Book Value (Per Share $) -1.03

Pacific Biosciences Of California Inc
realized net loss in trailing twelve months.

Pacific Biosciences Of California Inc realized cash outflow of $ -0.64per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
10.57
PE TTM    
Company's Price to Sales ratio is at 1.65.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.43.

Pacific Biosciences Of California Inc Price to Book Ratio is at 0.5 lower than Industry Avg. of 245.45. and higher than S&P 500 Avg. of 0.01

• More on PACB's Valuation

•  Market Capitalization (Millions $) 253
•  Shares Outstanding (Millions) 195
•  Employees 796
•  Revenues (TTM) (Millions $) 153
•  Net Income (TTM) (Millions $) -310
•  Cash Flow (TTM) (Millions $) -125
•  Capital Exp. (TTM) (Millions $) -7
•  Total Debt (Millions $) 647
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 192,565
•  Net Income/Employee(TTM) $ -389,260
•  Receivable Turnover Ratio (TTM) 5.12
•  Tangible Book Value (Per Share $) -1.03

•  Market Capitalization (Millions $) 253
•  Shares Outstanding (Millions) 195
•  Employees 796
•  Revenues (TTM) (Millions $) 153
•  Net Income (TTM) (Millions $) -310
•  Cash Flow (TTM) (Millions $) -125
•  Capital Exp. (TTM) (Millions $) -7





  Ratio
•   Capital Ratio (MRQ) 7.48
•  Total Debt to Equity (MRQ) 1.28
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.11
•  Inventory Turnover Ratio (TTM) 1.78





Pacific Biosciences Of California Inc net profit margin of 5.92 % is currently ranking no. 7 in Laboratory Analytical Instruments industry, ranking no. 131 in Healthcare sector and number 1514 in S&P 500.

• More on PACB's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com